Fig. 7 | Signal Transduction and Targeted Therapy

Fig. 7

From: Spi-1 proto-oncogene regulates mRNA hypertranscription and malignant progression in head and neck cancer

Fig. 7The alternative text for this image may have been generated using AI.

Integrative transcriptomic and epigenomic analyses of SPI1 function in HNSCC. a Heatmaps and averaged ChIP-seq signal profiles showing SPI1 occupancy around transcription start sites (TSSs) in SPI1-overexpressing SAS cells, with SPI1 ChIP-seq Rep1 and its corresponding input control shown separately. b Aggregated metagene profiles illustrating normalized SPI1 ChIP-seq read density relative to the TSS across two independent SPI1-OE ChIP replicates and matched input samples. c Circos plot showing the genome-wide chromosomal distribution of SPI1 ChIP-seq binding peaks. d Volcano plot of DEGs identified by RNA-seq following SPI1 overexpression. DEGs were defined using an FDR < 0.05 and a |log2FC| > 1. e Representative gene set enrichment analysis (GSEA) plots showing hallmark pathways enriched in SPI1-overexpressing cells. f Venn diagram depicting the overlap between genes upregulated upon SPI1 overexpression and genes annotated with SPI1 ChIP-seq binding peaks. g Bubble plot showing Gene Ontology (GO) biological process enrichment of genes coregulated by SPI1 transcriptional activation and direct chromatin binding; the dot size indicates the gene count, and the color represents the adjusted P value. h De novo motif analysis of SPI1 ChIP-seq binding peaks. i Dual-luciferase reporter assay measuring SPI1-dependent transcriptional activity in a doxycycline-inducible system over time (n = 3 independent experiments; mean ± SD; one-way ANOVA with Tukey’s post hoc test)

Back to article page